was read the article
array:24 [ "pii" => "S2173509313002262" "issn" => "21735093" "doi" => "10.1016/j.endoen.2013.12.012" "estado" => "S300" "fechaPublicacion" => "2013-12-01" "aid" => "523" "copyright" => "SEEN" "copyrightAnyo" => "2012" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Endocrinol Nutr. 2013;60:582.e1-582.e12" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1950 "formatos" => array:3 [ "EPUB" => 10 "HTML" => 1488 "PDF" => 452 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S1575092213001836" "issn" => "15750922" "doi" => "10.1016/j.endonu.2013.04.013" "estado" => "S300" "fechaPublicacion" => "2013-12-01" "aid" => "523" "copyright" => "SEEN" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Endocrinol Nutr. 2013;60:582.e1-582.e12" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 4518 "formatos" => array:3 [ "EPUB" => 24 "HTML" => 3710 "PDF" => 784 ] ] "es" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Documento de consenso</span>" "titulo" => "Guía de práctica clínica para el diagnóstico y tratamiento de la apoplejía hipofisaria" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "582.e1" "paginaFinal" => "582.e12" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Clinical practice guideline for the diagnosis and treatment of pituitary apoplexy" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2719 "Ancho" => 2156 "Tamanyo" => 400740 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Algoritmo de tratamiento de la apoplejía hipofisaria. RM: resonancia magnética; TC: tomografía axial computerizada.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Almudena Vicente, Beatriz Lecumberri, María Ángeles Gálvez" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Almudena" "apellidos" => "Vicente" ] 1 => array:2 [ "nombre" => "Beatriz" "apellidos" => "Lecumberri" ] 2 => array:2 [ "nombre" => "María Ángeles" "apellidos" => "Gálvez" ] 3 => array:1 [ "colaborador" => "en nombre del Grupo de Trabajo de Neuroendocrinología" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2173509313002262" "doi" => "10.1016/j.endoen.2013.12.012" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173509313002262?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1575092213001836?idApp=UINPBA00004N" "url" => "/15750922/0000006000000010/v1_201312050034/S1575092213001836/v1_201312050034/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2173509313002183" "issn" => "21735093" "doi" => "10.1016/j.endoen.2013.12.004" "estado" => "S300" "fechaPublicacion" => "2013-12-01" "aid" => "484" "copyright" => "SEEN" "documento" => "article" "crossmark" => 0 "subdocumento" => "ssu" "cita" => "Endocrinol Nutr. 2013;60:583-9" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1270 "formatos" => array:3 [ "EPUB" => 17 "HTML" => 943 "PDF" => 310 ] ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review article</span>" "titulo" => "Diabetes mellitus and depressive disorder, an undesirable association" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "583" "paginaFinal" => "589" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Diabetes mellitus y trastorno depresivo, un mal binomio" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Joana Nicolau, Lluís Masmiquel" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Joana" "apellidos" => "Nicolau" ] 1 => array:2 [ "nombre" => "Lluís" "apellidos" => "Masmiquel" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1575092213000922" "doi" => "10.1016/j.endonu.2013.01.011" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1575092213000922?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173509313002183?idApp=UINPBA00004N" "url" => "/21735093/0000006000000010/v2_201402070022/S2173509313002183/v2_201402070022/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2173509313002249" "issn" => "21735093" "doi" => "10.1016/j.endoen.2013.12.010" "estado" => "S300" "fechaPublicacion" => "2013-12-01" "aid" => "519" "copyright" => "SEEN" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Endocrinol Nutr. 2013;60:577-81" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1480 "formatos" => array:3 [ "EPUB" => 8 "HTML" => 1135 "PDF" => 337 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Special article</span>" "titulo" => "Overall child development: Beyond pharmacological iodine supplementation" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "577" "paginaFinal" => "581" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Desarrollo global del niño: más allá de la suplementación farmacológica con yodo" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2172 "Ancho" => 3105 "Tamanyo" => 503178 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Proposed framework of determinants of overall child development. IK: potassium iodide. Prepared by the authors from references <a class="elsevierStyleCrossRefs" href="#bib0015">3–6</a>.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Enrique Gavilán, Laura Jiménez de Gracia" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Enrique" "apellidos" => "Gavilán" ] 1 => array:2 [ "nombre" => "Laura" "apellidos" => "Jiménez de Gracia" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1575092213001794" "doi" => "10.1016/j.endonu.2013.04.010" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1575092213001794?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173509313002249?idApp=UINPBA00004N" "url" => "/21735093/0000006000000010/v2_201402070022/S2173509313002249/v2_201402070022/en/main.assets" ] "en" => array:20 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Consensus document</span>" "titulo" => "Clinical practice guideline for the diagnosis and treatment of pituitary apoplexy" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "582.e1" "paginaFinal" => "582.e12" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Almudena Vicente, Beatriz Lecumberri, María Ángeles Gálvez" "autores" => array:4 [ 0 => array:4 [ "nombre" => "Almudena" "apellidos" => "Vicente" "email" => array:2 [ 0 => "almudena@m3d.net" 1 => "avdelgado@sescam.jccm.es" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">¿</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Beatriz" "apellidos" => "Lecumberri" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "María Ángeles" "apellidos" => "Gálvez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 3 => array:2 [ "colaborador" => "on behalf of the Neuroendocrinology working group" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">◊</span>" "identificador" => "fn1" ] ] ] ] "afiliaciones" => array:3 [ 0 => array:3 [ "entidad" => "Servicio de Endocrinología y Nutrición, Hospital Virgen de la Salud, Complejo Hospitalario de Toledo, Toledo, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Servicio Endocrinología y Nutrición, Hospital Universitario La Paz de Madrid, Madrid, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Servicio Endocrinología y Nutrición, Hospital Universitario Reina Sofía de Córdoba, Spain" "etiqueta" => "c" "identificador" => "aff0015" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Guía de práctica clínica para el diagnóstico y tratamiento de la apoplejía hipofisaria" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2716 "Ancho" => 2156 "Tamanyo" => 382494 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Algorithm for the management of pituitary apoplexy. MRI: magnetic resonance imaging; CT: computed tomography.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Pituitary apoplexy (PA) is an acute, life-threatening clinical syndrome characterized by the sudden occurrence of headache, vomiting, visual changes with cranial nerve involvement, and decreased consciousness which is caused by pituitary gland hemorrhage and/or infarction. It is an endocrinological emergency. The diagnosis of PA requires a high level of suspicion, and different specialists should be involved in its management, including emergency physicians, neurosurgeons, ophthalmologists, and endocrinologists. There is however no clear consensus about the best option for the treatment of PA.</p><p id="par0010" class="elsevierStylePara elsevierViewall">These clinical guidelines should not be considered as a clinical practice standard. They are only intended to provide a number of recommendations for the diagnosis and treatment of patients with PA based on the currently available medical evidence that will make it possible to harmonize as much as possible its management in both the acute phase and long-term follow-up and so improve the professional care of these patients. However, the level of evidence on which these recommendations are based is low, as no prospective and/or randomized studies are available. Such studies are needed to provide a higher level of evidence that will allow for further improving the treatment of these patients.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Summary of recommendations</span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Recommendations for the initial clinical assessment</span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Clinical examination</span><p id="par0015" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0005"><li class="elsevierStyleListItem" id="lsti0005"><span class="elsevierStyleLabel">•</span><p id="par0020" class="elsevierStylePara elsevierViewall">A diagnosis of pituitary apoplexy should be considered in patients with severe acute headache, regardless of whether or not they have neuro-ophthalmic symptoms (√).</p></li><li class="elsevierStyleListItem" id="lsti0010"><span class="elsevierStyleLabel">•</span><p id="par0025" class="elsevierStylePara elsevierViewall">The initial clinical assessment should always include a complete history aimed at detecting pituitary dysfunction symptoms, and a physical examination including the examination of the cranial nerves and a confrontation campimetry (√).</p></li></ul></p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Ophthalmological assessment</span><p id="par0030" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0010"><li class="elsevierStyleListItem" id="lsti0015"><span class="elsevierStyleLabel">•</span><p id="par0035" class="elsevierStylePara elsevierViewall">If permitted by the clinical status of the patient, campimetry or perimetry (using a Humphrey visual analyzer or a Goldmann perimeter) should be performed within 24<span class="elsevierStyleHsp" style=""></span>h of the start of the condition (√).</p></li></ul></p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Laboratory tests. Endocrinological assessment</span><p id="par0040" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0015"><li class="elsevierStyleListItem" id="lsti0020"><span class="elsevierStyleLabel">•</span><p id="par0045" class="elsevierStylePara elsevierViewall">All patients in whom pituitary apoplexy is suspected should immediately have samples taken to test electrolytes, kidney function, liver function, coagulation, complete blood count, and pituitary function (cortisol, prolactin, free thyroxine, TSH, IGF-1, GH, LH, FSH, and estradiol in women of childbearing age and testosterone in men (IV, C).</p></li></ul></p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Radiographic assessment</span><p id="par0050" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0020"><li class="elsevierStyleListItem" id="lsti0025"><span class="elsevierStyleLabel">•</span><p id="par0055" class="elsevierStylePara elsevierViewall">All patients in whom pituitary apoplexy is suspected should urgently undergo magnetic resonance imaging (MRI) to confirm the diagnosis (III, B).</p></li></ul></p></span></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Recommendations for initial medical treatment</span><p id="par0060" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0025"><li class="elsevierStyleListItem" id="lsti0030"><span class="elsevierStyleLabel">•</span><p id="par0065" class="elsevierStylePara elsevierViewall">Frequent monitoring of water and electrolyte balance, measures to maintain hemodynamic stability, and treatment with high glucocorticoid doses (III, B).</p></li><li class="elsevierStyleListItem" id="lsti0035"><span class="elsevierStyleLabel">•</span><p id="par0070" class="elsevierStylePara elsevierViewall">Indications requiring the immediate empirical administration of glucocorticoids in patients with PA include hemodynamic instability, decreased consciousness, decreased visual acuity, and extensive visual field defects (IV, C).</p></li><li class="elsevierStyleListItem" id="lsti0040"><span class="elsevierStyleLabel">•</span><p id="par0075" class="elsevierStylePara elsevierViewall">Hydrocortisone 100–200<span class="elsevierStyleHsp" style=""></span>mg as a bolus, followed by 2–4<span class="elsevierStyleHsp" style=""></span>mg/hour as a continuous IV infusion, should preferably be used (√).</p></li><li class="elsevierStyleListItem" id="lsti0045"><span class="elsevierStyleLabel">•</span><p id="par0080" class="elsevierStylePara elsevierViewall">Once stabilization is achieved, patients should be transferred to a center where transsphenoidal neurosurgery and close ophthalmological and endocrinological monitoring may be performed (√).</p></li></ul></p></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Recommendations for surgery</span><p id="par0085" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0030"><li class="elsevierStyleListItem" id="lsti0050"><span class="elsevierStyleLabel">•</span><p id="par0090" class="elsevierStylePara elsevierViewall">Patients with impaired consciousness and/or decreased visual acuity and/or acute, persistent, or gradually impaired severe visual field defects should undergo surgery (III, B).</p></li><li class="elsevierStyleListItem" id="lsti0055"><span class="elsevierStyleLabel">•</span><p id="par0095" class="elsevierStylePara elsevierViewall">Surgery should preferably be performed within seven days of symptom occurrence (III, B).</p></li><li class="elsevierStyleListItem" id="lsti0060"><span class="elsevierStyleLabel">•</span><p id="par0100" class="elsevierStylePara elsevierViewall">The procedure should be performed by a neurosurgeon experienced in transsphenoidal surgery on an elective basis.</p></li></ul></p></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Recommendations for conservative management</span><p id="par0105" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0035"><li class="elsevierStyleListItem" id="lsti0065"><span class="elsevierStyleLabel">•</span><p id="par0110" class="elsevierStylePara elsevierViewall">Patients with no or mild and stable neuro-ophthalmological symptoms and/or signs may be managed conservatively under close supervision (III, B).</p></li><li class="elsevierStyleListItem" id="lsti0070"><span class="elsevierStyleLabel">•</span><p id="par0115" class="elsevierStylePara elsevierViewall">Neurological symptoms should initially be monitored every hour, but the interval may be lengthened to every four to six hours if the course of the disease is favorable and the patient is stable (√).</p></li><li class="elsevierStyleListItem" id="lsti0075"><span class="elsevierStyleLabel">•</span><p id="par0120" class="elsevierStylePara elsevierViewall">Visual acuity and visual field defects should be examined daily until a clear trend to improvement is seen (√).</p></li><li class="elsevierStyleListItem" id="lsti0080"><span class="elsevierStyleLabel">•</span><p id="par0125" class="elsevierStylePara elsevierViewall">Kidney function and electrolyte levels should be monitored every 24<span class="elsevierStyleHsp" style=""></span>h or more frequently if needed (√).</p></li></ul></p></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Recommendations for surgery in patients on initial conservative management</span><p id="par0130" class="elsevierStylePara elsevierViewall">In patients with impaired visual acuity or consciousness or a worsening of visual field defects, urgent MRI should be performed to plan for surgical decompression, including ventricular diversion in the event of hydrocephalus (IV, C).</p></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Recommendations for clinical monitoring in the early postoperative period</span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0120">Clinical examination</span><p id="par0135" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0040"><li class="elsevierStyleListItem" id="lsti0085"><span class="elsevierStyleLabel">•</span><p id="par0140" class="elsevierStylePara elsevierViewall">During the first 24 or 48<span class="elsevierStyleHsp" style=""></span>h after surgery, patients should closely be monitored to detect potential complications such as diabetes insipidus, vision loss, cerebrospinal fluid fistula, or adrenocorticotropic hormone/cortisol deficiency. Water balance should be recorded every hour (√).</p></li></ul></p></span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0125">Ophthalmological assessment</span><p id="par0145" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0045"><li class="elsevierStyleListItem" id="lsti0090"><span class="elsevierStyleLabel">•</span><p id="par0150" class="elsevierStylePara elsevierViewall">Visual acuity, eye movements, and confrontation campimetry should regularly be examined for the first 48<span class="elsevierStyleHsp" style=""></span>h at the patient's bedside, and when possible, an instrumental examination should be performed (a Humphrey analyzer or a Goldmann perimeter) (IV, C).</p></li></ul></p></span><span id="sec0075" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0130">Laboratory tests. Endocrinological assessment</span><p id="par0155" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0050"><li class="elsevierStyleListItem" id="lsti0095"><span class="elsevierStyleLabel">•</span><p id="par0160" class="elsevierStylePara elsevierViewall">Kidney function and plasma electrolytes and plasma and urine osmolality should be assessed in the first 24 or 48<span class="elsevierStyleHsp" style=""></span>h. These measurements should be performed at least once daily, and more frequently if required by the clinical status (IV, C).</p></li><li class="elsevierStyleListItem" id="lsti0100"><span class="elsevierStyleLabel">•</span><p id="par0165" class="elsevierStylePara elsevierViewall">Cortisol levels should be measured at 09:00 AM on the second or third day after surgery in patients with no prior evidence of ACTH/cortisol deficiency. This will require the discontinuation of hydrocortisone in the evening before sampling (IV, C).</p></li><li class="elsevierStyleListItem" id="lsti0105"><span class="elsevierStyleLabel">•</span><p id="par0170" class="elsevierStylePara elsevierViewall">In patients with ACTH/cortisol deficiency before surgery, treatment with hydrocortisone should be continued until the maintenance dose is achieved. These patients should be re-evaluated at 4 or 8 weeks to determine whether they will require long-term treatment (IV, C).</p></li><li class="elsevierStyleListItem" id="lsti0110"><span class="elsevierStyleLabel">•</span><p id="par0175" class="elsevierStylePara elsevierViewall">Free thyroxine and TSH levels should be measured on the third or fourth day after surgery. If normal levels are found, they should be measured again at 4 or 8 weeks (IV, C).</p></li></ul></p></span><span id="sec0080" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0135">Radiographic assessment</span><p id="par0180" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0055"><li class="elsevierStyleListItem" id="lsti0115"><span class="elsevierStyleLabel">•</span><p id="par0185" class="elsevierStylePara elsevierViewall">If visual impairment is found, urgent MRI should be performed and the patient should urgently be re-evaluated by the neurosurgical team (√).</p></li></ul></p></span></span><span id="sec0085" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0140">Recommendations for mid or long-term follow-up</span><p id="par0825" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0060"><li class="elsevierStyleListItem" id="lsti0120"><span class="elsevierStyleLabel">•</span><p id="par0195" class="elsevierStylePara elsevierViewall">All patients who have experienced PA should be assessed 4 or 8 weeks after the acute episode. Pituitary function tests (baseline measurements and, when indicated, the relevant stimulation/suppression tests), cranial nerve examination, and campimetry and, optionally, optical coherence tomography (OCT) should be performed (√).</p></li><li class="elsevierStyleListItem" id="lsti0125"><span class="elsevierStyleLabel">•</span><p id="par0200" class="elsevierStylePara elsevierViewall">All patients who have experienced apoplexy should be assessed annually using biochemical tests and pituitary function tests including cortisol, free thyroxine, TSH, LH, FSH, testosterone in men, estradiol in women of childbearing age, prolactin, IGF-1, and dynamic cortisol and GH tests if clinically indicated (√).</p></li><li class="elsevierStyleListItem" id="lsti0130"><span class="elsevierStyleLabel">•</span><p id="par0205" class="elsevierStylePara elsevierViewall">Patients who have experienced apoplexy and have residual tumor will require radiographic follow-up (MRI) and, when indicated, should complete treatment with repeat surgery, medical treatment, or radiotherapy (III, B).</p></li><li class="elsevierStyleListItem" id="lsti0135"><span class="elsevierStyleLabel">•</span><p id="par0210" class="elsevierStylePara elsevierViewall">Control MRI is recommended 3 or 6 months after apoplexy. If residual tumor or recurrence is found, monitoring is recommended every year during the first 3 or 5 years, and every 2 or 3 years thereafter (IV, C).</p></li><li class="elsevierStyleListItem" id="lsti0140"><span class="elsevierStyleLabel">•</span><p id="par0215" class="elsevierStylePara elsevierViewall">At least annual monitoring is required in all patients. It is recommended that patients be followed up by a multidisciplinary team experienced in pituitary diseases (endocrinologists, neurosurgeons, ophthalmologists, and radiologists) (√).</p></li></ul></p></span></span><span id="sec0090" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0145">Preparation method</span><p id="par0220" class="elsevierStylePara elsevierViewall">These guidelines were prepared at the suggestion of the scientific committee of the Neuroendocrinology Group (GNE) of the Spanish Society of Endocrinology and Nutrition (SEEN) within the program for updating clinical practice guidelines in neuroendocrinology. In 2006, the Working Group of Neuroendocrinology of the SEEN issued the Clinical Guidelines for the Diagnosis and Treatment of Pituitary Apoplexy<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a>. Based on this initial publication, and on the British clinical practice guidelines published on 2011,<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> these guidelines have been updated and adapted to the format used in most international medical journals. To this end, after a literature review, the quality of evidence and the weight of the recommendations were assessed using the system proposed in 2004 by the Agency for Health Care Policy and Research (AHCPR), currently called the Agency for Healthcare Research and Quality (AHRQ)<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a>.</p><span id="sec0095" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0150">Levels of evidence and grades of recommendation used (based on the system proposed by the Agency for Health Care Policy and Research)</span><span id="sec0100" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0155">Levels of evidence</span><p id="par0225" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0065"><li class="elsevierStyleListItem" id="lsti0145"><p id="par0230" class="elsevierStylePara elsevierViewall">Ia: Evidence obtained from meta-analyses of high quality clinical trials (controlled and randomized).</p></li><li class="elsevierStyleListItem" id="lsti0150"><p id="par0235" class="elsevierStylePara elsevierViewall">Ib: Evidence obtained from at least one high quality clinical trial.</p></li><li class="elsevierStyleListItem" id="lsti0155"><p id="par0240" class="elsevierStylePara elsevierViewall">IIa: Evidence obtained from one well-designed, controlled, nonrandomized study.</p></li><li class="elsevierStyleListItem" id="lsti0160"><p id="par0245" class="elsevierStylePara elsevierViewall">IIb: Evidence obtained from at least one well-designed, quasi-experimental study.</p></li><li class="elsevierStyleListItem" id="lsti0165"><p id="par0250" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleSmallCaps">III</span>: Evidence obtained from well-designed descriptive studies and case and control studies.</p></li><li class="elsevierStyleListItem" id="lsti0170"><p id="par0255" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleSmallCaps">IV</span>: Expert opinion.</p></li></ul></p></span><span id="sec0105" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0160">Grades of recommendation</span><p id="par0260" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0070"><li class="elsevierStyleListItem" id="lsti0175"><span class="elsevierStyleLabel">A</span><p id="par0265" class="elsevierStylePara elsevierViewall">Level of evidence Ia or Ib.</p></li><li class="elsevierStyleListItem" id="lsti0180"><span class="elsevierStyleLabel">B</span><p id="par0270" class="elsevierStylePara elsevierViewall">Level of evidence IIa, IIb, or III.</p></li><li class="elsevierStyleListItem" id="lsti0185"><span class="elsevierStyleLabel">C</span><p id="par0275" class="elsevierStylePara elsevierViewall">Level of evidence IV.</p></li></ul><ul class="elsevierStyleList" id="lis0075"><li class="elsevierStyleListItem" id="lsti0190"><p id="par0280" class="elsevierStylePara elsevierViewall">√ Good clinical practice.</p></li></ul></p><p id="par0285" class="elsevierStylePara elsevierViewall">After a literature review of each of the different sections, a series of recommendations are given. The level of evidence appears in brackets after each recommendation, followed by the grade of recommendation.</p></span></span></span><span id="sec0110" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0165">Definition</span><p id="par0290" class="elsevierStylePara elsevierViewall">The term PA, initially coined by Brougham et al. in 1950,<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> is traditionally used to refer to an acute, life-threatening clinical syndrome characterized by the sudden onset of headache, vomiting, visual impairment, and decreased consciousness caused by pituitary hemorrhage or infarction. The syndrome was first described by Bailey<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> in 1898. Syndrome definition is more clinical than pathological, because asymptomatic pituitary hemorrhage and/or infarction may be radiographic, surgical, or histopathological findings and should not be diagnosed as PA.<a class="elsevierStyleCrossRefs" href="#bib0030"><span class="elsevierStyleSup">6,7</span></a></p><p id="par0295" class="elsevierStylePara elsevierViewall">PA may have two different clinical presentations:<ul class="elsevierStyleList" id="lis0080"><li class="elsevierStyleListItem" id="lsti0195"><span class="elsevierStyleLabel">-</span><p id="par0300" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Acute PA.</span> This is considered a life-threatening neuroendocrinological emergency that requires neurosurgical decompression in the vast majority of cases.<a class="elsevierStyleCrossRefs" href="#bib0030"><span class="elsevierStyleSup">6,7</span></a></p></li><li class="elsevierStyleListItem" id="lsti0200"><span class="elsevierStyleLabel">-</span><p id="par0305" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Subacute or subclinical PA.</span> This has a slower, more torpid course and milder clinical signs and symptoms, is more common than the classical form and can be managed more conservatively, at least initially.<a class="elsevierStyleCrossRefs" href="#bib0035"><span class="elsevierStyleSup">7–9</span></a></p></li></ul></p></span><span id="sec0115" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0170">Epidemiology</span><p id="par0310" class="elsevierStylePara elsevierViewall">The incidence of acute PA in pituitary adenomas ranges from 0.6% to 9% depending on the series,<a class="elsevierStyleCrossRefs" href="#bib0040"><span class="elsevierStyleSup">8,10–13</span></a> while the incidence rate of the subacute or subclinical form is up to 14–22%.<a class="elsevierStyleCrossRefs" href="#bib0050"><span class="elsevierStyleSup">10,12–14</span></a> PA affects more patients between the fifth and sixth decades of life, and is more frequent in males (1.6/1).<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">11–15</span></a></p><p id="par0315" class="elsevierStylePara elsevierViewall">Apoplexy is the first manifestation of pituitary adenoma in up to 80% of patients.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> It may occur in both functioning and non-functioning pituitary adenomas,<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">11</span></a> but more commonly occurs in the latter due to the absence of a clinical hormone hyperfunction syndrome giving the alert about tumor existence. It has been reported to occur within non-adenomatous lesions such as craniopharyngiomas, pituitary cysts, and hypophysitis.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a></p><p id="par0320" class="elsevierStylePara elsevierViewall">In patients with PA, pathological study shows the presence of hemorrhagic infarction, bleeding, necrosis, or intratumoral cystic changes.<a class="elsevierStyleCrossRefs" href="#bib0065"><span class="elsevierStyleSup">13,16</span></a> Most series make no clear distinction between pure infarction and hemorrhage or hemorrhagic infarction. Some authors have reported that hemorrhage and hemorrhagic infarction are more frequently associated with the presence of a precipitating factor, a more severe clinical picture, and a poorer prognosis as compared to non-hemorrhagic infarction.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> However, small hemorrhagic areas, hemorrhagic infarction, or infarction have been found in imaging tests, during surgery, or in histopathological studies in up to 25% of pituitary macroadenomas,<a class="elsevierStyleCrossRefs" href="#bib0030"><span class="elsevierStyleSup">6,15,16</span></a> in most of which there were no apparent clinical signs. These cases cannot therefore be considered as PA.</p></span><span id="sec0120" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0175">Pathophysiology</span><p id="par0325" class="elsevierStylePara elsevierViewall">The clinical signs of PA are caused by a rapid increase in the size of the intrasellar contents and the resultant increase in intrasellar pressure (median pressure of 47<span class="elsevierStyleHsp" style=""></span>mmHg in PA versus 7–15<span class="elsevierStyleHsp" style=""></span>mmHg under normal conditions), which causes the mechanical compression of optic tracts and internal cavernous sinus structures.<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">17</span></a> The hemorrhage is usually encapsulated inside the tumor, but extravasation of blood into the subarachnoid space often occurs, leading to meningeal irritation symptoms. In large macroadenomas with suprasellar extension, obstructive hydrocephalus may occur as a complication of PA.</p><p id="par0330" class="elsevierStylePara elsevierViewall">Lateral compression may affect cavernous sinus contents, causing oculomotor nerve palsy (ophthalmoplegia) in 70% of patients, with the third cranial nerve being most commonly affected.<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">18</span></a> Upper optic chiasm compression causes visual acuity impairment and campimetric defects such as bitemporal hemianopsia in approximately 75% of patients.<a class="elsevierStyleCrossRefs" href="#bib0040"><span class="elsevierStyleSup">8,10,12</span></a> Lower optic chiasm compression may lead to the destruction of the sellar floor with cerebrospinal fluid fistula.<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">17</span></a></p><p id="par0335" class="elsevierStylePara elsevierViewall">A rapid and marked increase in intrasellar pressure will also cause ischemic necrosis of the anterior pituitary gland due to direct compression of the normal pituitary gland and decreased blood supply to the gland.<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">17</span></a> Hypopituitarism will occur as a consequence of such destruction.<a class="elsevierStyleCrossRefs" href="#bib0095"><span class="elsevierStyleSup">19,20</span></a> Seventy-five to 90% of the gland must be destroyed for permanent hormone deficiencies to occur.<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">17</span></a></p><span id="sec0125" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0180">Precipitating factors</span><p id="par0340" class="elsevierStylePara elsevierViewall">Precipitating factors have been identified in up to 40% of cases of PA<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">12</span></a> (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). The most common factors include high blood pressure (26%),<a class="elsevierStyleCrossRefs" href="#bib0040"><span class="elsevierStyleSup">8,12</span></a> anticoagulation, and major surgery, especially coronary bypass surgery.<a class="elsevierStyleCrossRefs" href="#bib0105"><span class="elsevierStyleSup">21,22</span></a> In the latter, PA is mainly due to blood pressure fluctuations and the use of anticoagulant therapy.<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">23</span></a></p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0345" class="elsevierStylePara elsevierViewall">Other promoting or precipitating factors include the dynamic tests used to assess pituitary function, such as those to measure GnRH, TRH, CRH, and insulin-induced hypoglycemia. Apoplexy occurred within two hours of the tests in 83% of patients, and within 88<span class="elsevierStyleHsp" style=""></span>h in all patients.<a class="elsevierStyleCrossRef" href="#bib0120"><span class="elsevierStyleSup">24</span></a></p><p id="par0350" class="elsevierStylePara elsevierViewall">Anticoagulation, coagulopathies, the start or discontinuation of treatment with dopamine agonists<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">10</span></a> or estrogens, radiotherapy,<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">16</span></a> pregnancy,<a class="elsevierStyleCrossRef" href="#bib0125"><span class="elsevierStyleSup">25</span></a> and head trauma may also induce the development of PA. Partial resection of a macroadenoma represents another risk factor because of compromised supply in the postoperative remnant.<a class="elsevierStyleCrossRef" href="#bib0130"><span class="elsevierStyleSup">26</span></a></p><p id="par0355" class="elsevierStylePara elsevierViewall">Adenomas secreting GH and ACTH, as well as large non-functioning adenomas, especially silent corticotropinomas, have been reported to be associated with a high risk of apoplexy<a class="elsevierStyleCrossRef" href="#bib0135"><span class="elsevierStyleSup">27</span></a> (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>).</p></span></span><span id="sec0130" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0185">Clinical signs</span><p id="par0360" class="elsevierStylePara elsevierViewall">The clinical picture usually evolves within hours or days<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> depending on hemorrhage severity and volume, the presence of associated endocrine signs, and the parasellar structures involved. <span class="elsevierStyleItalic">Acute</span> PA with severe neurological deficiencies evolves in 24 or 48<span class="elsevierStyleHsp" style=""></span>h and is considered as a life-threatening neuroendocrinological emergency that requires immediate surgical decompression.<a class="elsevierStyleCrossRefs" href="#bib0035"><span class="elsevierStyleSup">7,8</span></a> In <span class="elsevierStyleItalic">subacute</span> or “<span class="elsevierStyleItalic">subclinical</span>” <span class="elsevierStyleItalic">PA</span>, pituitary hemorrhage and/or infarction evolution may be slower and more insidious, with mild clinical signs.<a class="elsevierStyleCrossRefs" href="#bib0035"><span class="elsevierStyleSup">7–9</span></a></p><p id="par0365" class="elsevierStylePara elsevierViewall">The most common symptom is headache, which is usually retro-orbital, although bifrontal or suboccipital headache may also be reported. The onset of headache is sudden and severe, is often associated with vomiting, and usually precedes all other symptoms.<a class="elsevierStyleCrossRefs" href="#bib0060"><span class="elsevierStyleSup">12,13,17,28</span></a></p><p id="par0370" class="elsevierStylePara elsevierViewall">Visual involvement is common and occurs as oculomotor paresis. Symptoms of involvement of the 3rd cranial nerve are found in 50% of patients.<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">10</span></a> Diplopia occurs in a high number of cases (67%).<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a> Variable visual acuity decrease (ranging from campimetric defects to bilateral amaurosis) and impairment consciousness may also occur (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>).</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0375" class="elsevierStylePara elsevierViewall">Seizures, hemiplegia due to brainstem compression, and diabetes insipidus have exceptionally been reported<a class="elsevierStyleCrossRefs" href="#bib0020"><span class="elsevierStyleSup">4,10</span></a> (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>).</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><p id="par0380" class="elsevierStylePara elsevierViewall">As regards symptoms due to hormone dysfunction, almost 80% of patients have some deficiency of anterior pituitary hormones at the start of the condition, related to the presence of an undiagnosed microadenoma.<a class="elsevierStyleCrossRef" href="#bib0145"><span class="elsevierStyleSup">29</span></a> ACTH/cortisol deficiency is found in 70% of patients. This is the most significant deficiency due to its attendant risk, given that acute adrenal insufficiency is the main cause of mortality and occurs as hemodynamic instability. GH, LH/FSH, and TSH deficiencies usually occur in more than 80%, 75%, and 60% of cases, respectively.<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">11,12,18,19</span></a></p><p id="par0385" class="elsevierStylePara elsevierViewall">Hyponatremia has been reported in 40% of patients, and is related to either inappropriate antidiuretic hormone secretion or hypocortisolism.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a> Diabetes insipidus occurs less commonly.<a class="elsevierStyleCrossRef" href="#bib0105"><span class="elsevierStyleSup">21</span></a></p><p id="par0390" class="elsevierStylePara elsevierViewall">Prolactin levels may vary depending on the extent of pituitary ischemic necrosis. Some authors have suggested that normal or slightly elevated prolactin levels indicate a lower degree of gland destruction and, thus, a greater chance of pituitary function recovery after decompression surgery.<a class="elsevierStyleCrossRefs" href="#bib0085"><span class="elsevierStyleSup">17,19</span></a></p></span><span id="sec0135" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0190">Diagnosis</span><p id="par0395" class="elsevierStylePara elsevierViewall">Acute PA often mimics the clinical picture of other more frequent neurological emergencies, and initial diagnosis of the condition may therefore be difficult. Differential diagnosis should mainly be made with subarachnoidal hemorrhage and bacterial meningitis. Midbrain infarction (basilar artery occlusion) or cavernous sinus thrombosis, although less common, should also be considered.</p><p id="par0400" class="elsevierStylePara elsevierViewall">Simultaneous or sequential occurrence of the following symptoms and signs will strongly suggest the presence of PA:<ul class="elsevierStyleList" id="lis0085"><li class="elsevierStyleListItem" id="lsti0205"><span class="elsevierStyleLabel">1</span><p id="par0405" class="elsevierStylePara elsevierViewall">Sudden, continuous, predominantly retro-orbital headache.</p></li><li class="elsevierStyleListItem" id="lsti0210"><span class="elsevierStyleLabel">2</span><p id="par0410" class="elsevierStylePara elsevierViewall">Diplopia associated with visual field and/or visual acuity reduction.</p></li><li class="elsevierStyleListItem" id="lsti0215"><span class="elsevierStyleLabel">3</span><p id="par0415" class="elsevierStylePara elsevierViewall">Impaired consciousness.</p></li></ul></p><p id="par0420" class="elsevierStylePara elsevierViewall">MRI is the imaging test of choice because it confirms the suspected diagnosis in more than 90% of cases and allows for differential diagnosis with other neurological emergencies. MRI should be performed immediately in the event of visual impairment. Computed tomography (CT) only diagnoses less than 30% of PAs, but discloses the presence of a sellar mass in more than 80% of cases.<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">11–14</span></a> In the initial phase, MRI usually shows a pituitary mass with hyperintense heterogeneous signal mainly in T1-weighted images and hypointense signal in T2-weighted images. Images of T2-weighted gradient echo sequences show the intratumoral hemorrhage in the acute phase as a very dark lesion that contrasts with adjacent structures. In subacute apoplexy, hemorrhage is seen in T2-weighted gradient echo sequence images as a dark ring.<a class="elsevierStyleCrossRef" href="#bib0150"><span class="elsevierStyleSup">30</span></a></p><p id="par0425" class="elsevierStylePara elsevierViewall">The test of choice to assess potential optic tract lesion is campimetry or perimetry. Although visual perimetry (a Humphrey visual analyzer or a Goldmann perimeter) allows for the objective assessment of visual field involvement, it is not helpful in establishing a prognosis about the course of campimetric damage. OCT is a simple examination that provides an image of the retina and optic disk and quantifies neuron loss at this level. OCT is very helpful for studying macular disease and has increasing applications in assessing neuron loss in the central nervous system, by extrapolating the findings in the retinal nerve fiber layer (RNFL) to macular and peripapillary level. This test may be very useful for the diagnosis and monitoring of patients with chiasm compression by pituitary tumors. Different studies have reported that the thinning of the RNFL at three months of surgical decompression is associated with a poor prognosis,<a class="elsevierStyleCrossRefs" href="#bib0135"><span class="elsevierStyleSup">27,31,32</span></a> although one study concluded that OCT findings do not always correlate to campimetric changes.<a class="elsevierStyleCrossRef" href="#bib0165"><span class="elsevierStyleSup">33</span></a> Prospective studies are therefore needed to assess the prognostic value of OCT as a predictor of visual recovery after the treatment of patients with pituitary adenoma.</p><span id="sec0140" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0195">Recommendations for clinical assessment at the onset of pituitary apoplexy</span><span id="sec0145" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0200">Clinical examination</span><p id="par0430" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0090"><li class="elsevierStyleListItem" id="lsti0220"><span class="elsevierStyleLabel">•</span><p id="par0435" class="elsevierStylePara elsevierViewall">A diagnosis of pituitary apoplexy should be considered in patients with severe acute headache, regardless of whether or not they have neuro-ophthalmic symptoms (√).</p></li><li class="elsevierStyleListItem" id="lsti0225"><span class="elsevierStyleLabel">•</span><p id="par0440" class="elsevierStylePara elsevierViewall">Patients diagnosed with pituitary adenoma should be warned of the possibility of apoplexy and its symptoms, particularly when they have precipitating factors (anticoagulant treatment, surgery with extracorporeal circulation, major surgery, etc.) (√).</p></li><li class="elsevierStyleListItem" id="lsti0230"><span class="elsevierStyleLabel">•</span><p id="par0445" class="elsevierStylePara elsevierViewall">Clinical initial assessment must always include a complete history aimed at detecting pituitary dysfunction symptoms, and a physical examination including the examination of the cranial nerves and confrontational campimetry (√).</p></li></ul></p></span><span id="sec0150" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0205">Ophthalmological assessment</span><p id="par0455" class="elsevierStylePara elsevierViewall">If permitted by the clinical status of the patient, campimetry or perimetry (using a Humphrey visual analyzer or a Goldmann perimeter) should be performed within 24<span class="elsevierStyleHsp" style=""></span>h of the start of the condition (√).</p></span><span id="sec0155" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0210">Laboratory tests. Endocrinological assessment</span><p id="par0460" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0095"><li class="elsevierStyleListItem" id="lsti0235"><span class="elsevierStyleLabel">•</span><p id="par0465" class="elsevierStylePara elsevierViewall">All patients in whom pituitary apoplexy is suspected should immediately have samples taken to test electrolytes, kidney function, liver function, coagulation, complete blood count, and pituitary function (cortisol, prolactin, free thyroxine, TSH, IGF-1, GH, LH, FSH, and estradiol in women of childbearing age and testosterone in men (IV, C).</p></li><li class="elsevierStyleListItem" id="lsti0240"><span class="elsevierStyleLabel">•</span><p id="par0470" class="elsevierStylePara elsevierViewall">In hemodynamically unstable patients, in whom support measures should be started immediately, blood samples for thyroid hormone (TSH, free thyroxine) and cortisol measurements should be taken before hydrocortisone IV is administered (IV, C).</p></li><li class="elsevierStyleListItem" id="lsti0245"><span class="elsevierStyleLabel">•</span><p id="par0475" class="elsevierStylePara elsevierViewall">If samples cannot be directly sent to the laboratory at the time the patient is first seen, a serum sample should be stored for subsequent tests (√).</p></li></ul></p></span><span id="sec0160" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0215">Radiographic assessment</span><p id="par0480" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0100"><li class="elsevierStyleListItem" id="lsti0250"><span class="elsevierStyleLabel">•</span><p id="par0485" class="elsevierStylePara elsevierViewall">All patients in whom pituitary apoplexy is suspected should urgently undergo MRI to confirm diagnosis (III, B).</p></li><li class="elsevierStyleListItem" id="lsti0255"><span class="elsevierStyleLabel">•</span><p id="par0490" class="elsevierStylePara elsevierViewall">CT is indicted if MRI is contraindicated or cannot be performed (IV, C).</p></li></ul></p></span></span></span><span id="sec0165" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0220">Treatment</span><p id="par0495" class="elsevierStylePara elsevierViewall">The treatment of PA is based on two therapeutic mainstays:</p><span id="sec0170" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0225">Medical treatment</span><p id="par0500" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0105"><li class="elsevierStyleListItem" id="lsti0260"><span class="elsevierStyleLabel">-</span><p id="par0505" class="elsevierStylePara elsevierViewall">This is based on the use of high-dose glucocorticoids, the control of water and electrolyte disorders, the maintenance of hemodynamic stability if required, and the treatment of hormone deficiencies.<a class="elsevierStyleCrossRefs" href="#bib0040"><span class="elsevierStyleSup">8,12,15</span></a></p></li><li class="elsevierStyleListItem" id="lsti0265"><span class="elsevierStyleLabel">-</span><p id="par0510" class="elsevierStylePara elsevierViewall">The use of high-dose glucocorticoids is based on the presence of adrenal insufficiency and on their anti-inflammatory and antiedematous effects. Low plasma cortisol levels induce a lower vascular response to catecholamines, which promotes hemodynamic instability. They also increase vasopressin release, which results in decreased free water excretion, leading to hyponatremia. Glucocorticoid treatment should therefore be started in patients with hemodynamic stability and/or symptoms and signs of hypocortisolism before their cortisol levels are known.<a class="elsevierStyleCrossRefs" href="#bib0010"><span class="elsevierStyleSup">2,34</span></a></p></li><li class="elsevierStyleListItem" id="lsti0270"><span class="elsevierStyleLabel">-</span><p id="par0515" class="elsevierStylePara elsevierViewall">The 2011 clinical guidelines<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> advocate the use of hydrocortisone as an initial 100–200<span class="elsevierStyleHsp" style=""></span>mg IV bolus, followed by a continuous infusion (2–4<span class="elsevierStyleHsp" style=""></span>mg/h) or 50–100<span class="elsevierStyleHsp" style=""></span>mg by the intramuscular (IM) route every 6 or 8<span class="elsevierStyleHsp" style=""></span>h. The reason for this scheme is that the administration of hydrocortisone as IV boluses every 6 or 8<span class="elsevierStyleHsp" style=""></span>h results in the saturation of cortisol-binding protein, so that a large amount of the hydrocortisone will be filtered in the kidney without exerting an effect. Potent long-lasting steroids (dexamethasone 2–16<span class="elsevierStyleHsp" style=""></span>mg/day) are not considered a good option, but may be initially helpful to decrease edema if no early surgical decompression is performed. Mannitol may be added as needed.</p></li><li class="elsevierStyleListItem" id="lsti0275"><span class="elsevierStyleLabel">-</span><p id="par0520" class="elsevierStylePara elsevierViewall">If improvement occurs after the acute episode, a rapid decrease in glucocorticoid dosage to oral hydrocortisone 20–30<span class="elsevierStyleHsp" style=""></span>mg daily in three divided doses is recommended.<a class="elsevierStyleCrossRefs" href="#bib0010"><span class="elsevierStyleSup">2,34</span></a></p></li></ul></p></span><span id="sec0175" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0230">Recommendations for initial medical treatment</span><p id="par0525" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0110"><li class="elsevierStyleListItem" id="lsti0280"><span class="elsevierStyleLabel">•</span><p id="par0530" class="elsevierStylePara elsevierViewall">Frequent monitoring of water and electrolyte balance, measures to maintain hemodynamic stability, and treatment with high corticosteroid doses (III, B).</p></li><li class="elsevierStyleListItem" id="lsti0285"><span class="elsevierStyleLabel">•</span><p id="par0535" class="elsevierStylePara elsevierViewall">Indications for the urgent empirical administration of glucocorticoids in patients with PA include hemodynamic instability, decreased consciousness, decreased visual acuity, and extensive visual field defects (IV, C).</p></li><li class="elsevierStyleListItem" id="lsti0290"><span class="elsevierStyleLabel">•</span><p id="par0540" class="elsevierStylePara elsevierViewall">Hydrocortisone 100–200<span class="elsevierStyleHsp" style=""></span>mg as a bolus, followed by 2–4<span class="elsevierStyleHsp" style=""></span>mg/hour as a continuous IV infusion, should preferably be used. Alternatively, 50–100<span class="elsevierStyleHsp" style=""></span>mg IM every 6<span class="elsevierStyleHsp" style=""></span>h may be administered. Blood samples should first be taken for hormone and general laboratory tests as indicated in the laboratory test section. High-dose dexamethasone may initially be used in patients with cerebral edema (IV, C).</p></li><li class="elsevierStyleListItem" id="lsti0295"><span class="elsevierStyleLabel">•</span><p id="par0545" class="elsevierStylePara elsevierViewall">In patients not meeting the above criteria, but with cortisol levels at 09:00<span class="elsevierStyleHsp" style=""></span>h less than 550<span class="elsevierStyleHsp" style=""></span>nmol/L (15<span class="elsevierStyleHsp" style=""></span>μg/dL), steroids should also be administered with the same scheme (<span class="elsevierStyleSmallCaps">IV</span>, C).</p></li><li class="elsevierStyleListItem" id="lsti0300"><span class="elsevierStyleLabel">•</span><p id="par0550" class="elsevierStylePara elsevierViewall">Once stabilization is achieved, patients should be transferred to a center where transsphenoidal neurosurgery and close ophthalmological and endocrinological monitoring may be performed (√).</p></li></ul></p></span><span id="sec0180" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0235">Surgery</span><p id="par0555" class="elsevierStylePara elsevierViewall">Surgical decompression, preferably by the transsphenoidal approach, is required. No agreement exists, however, as to whether surgery should always be performed or as to the time when it is most convenient.<a class="elsevierStyleCrossRefs" href="#bib0040"><span class="elsevierStyleSup">8,12,18</span></a> There are no prospective, randomized clinical studies on which recommendations may be based, and the currently available scientific evidence comes from retrospective studies and case reports. The transsphenoidal approach is preferred in most patients due to its low morbidity and mortality.</p><p id="par0560" class="elsevierStylePara elsevierViewall">It should be stressed that, once stabilized, patients should be managed at hospitals where neurosurgical treatment is available, preferably at those with experience in transsphenoidal surgery,<a class="elsevierStyleCrossRefs" href="#bib0010"><span class="elsevierStyleSup">2,34</span></a> and where close ophthalmological and endocrinological monitoring may be performed. The British clinical guidelines for PA management consider surgeons who perform five or more procedures by the transsphenoidal approach every year to be expert.<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a></p><p id="par0565" class="elsevierStylePara elsevierViewall">Most literature series advise urgent surgery in patients with impaired consciousness, hypothalamic involvement, the sudden onset of amaurosis, or decreased visual acuity.<a class="elsevierStyleCrossRefs" href="#bib0040"><span class="elsevierStyleSup">8,12,34,35</span></a> Surgery is also advised for patients with a worsening of campimetric defects and/or progressive impairment of visual acuity and/or neurological symptoms.<a class="elsevierStyleCrossRefs" href="#bib0040"><span class="elsevierStyleSup">8,12</span></a></p><p id="par0570" class="elsevierStylePara elsevierViewall">Older retrospective series advocate decompression surgery in all cases<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a> based on the improvements in visual acuity, campimetric defects, ophthalmoplegia, and hormone deficiencies seen in most patients.<a class="elsevierStyleCrossRef" href="#bib0140"><span class="elsevierStyleSup">28</span></a> Such improvements already occur in the early postoperative period and continue for several weeks after surgery.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a> Different studies have reported that improvement is more complete if surgery is performed within seven days of the onset of symptoms.<a class="elsevierStyleCrossRefs" href="#bib0040"><span class="elsevierStyleSup">8,13,36,37</span></a></p></span><span id="sec0185" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0240">Recommendations for surgery</span><p id="par0575" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0115"><li class="elsevierStyleListItem" id="lsti0305"><span class="elsevierStyleLabel">•</span><p id="par0580" class="elsevierStylePara elsevierViewall">Patients with impaired consciousness and/or decreased visual acuity and/or acute, persistent, or gradually impaired severe visual field defects should undergo surgery (III, B).</p></li><li class="elsevierStyleListItem" id="lsti0310"><span class="elsevierStyleLabel">•</span><p id="par0585" class="elsevierStylePara elsevierViewall">Surgery should preferably be performed within seven days of symptom occurrence (III, B).</p></li><li class="elsevierStyleListItem" id="lsti0315"><span class="elsevierStyleLabel">•</span><p id="par0590" class="elsevierStylePara elsevierViewall">The procedure should be performed by a neurosurgeon experienced in transsphenoidal surgery on an elective basis. Urgent decompression by a neurosurgeon on duty call with no experience in this procedure should only be reserved for severe cases requiring immediate surgery (IV, C).</p></li></ul></p></span><span id="sec0190" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0245">Surgical versus conservative management</span><p id="par0600" class="elsevierStylePara elsevierViewall">Recent retrospective studies<a class="elsevierStyleCrossRefs" href="#bib0030"><span class="elsevierStyleSup">6,38–40</span></a> report that patients with mainly oculomotor involvement, with no decreased consciousness, and with vision improvement in the first few days may be managed with conservative treatment alone. In these patients, the ophthalmological and endocrinological prognosis does not differ from that of patients treated with surgery. However, the bias involved in the fact that the patients undergoing surgery are usually those with severe symptoms at the start or with a poorer course after conservative management should be taken into account.</p><p id="par0605" class="elsevierStylePara elsevierViewall">Another patient subgroup amenable to conservative management includes those with a milder clinical presentation (subclinical pituitary apoplexy).<a class="elsevierStyleCrossRefs" href="#bib0070"><span class="elsevierStyleSup">14,40</span></a></p><p id="par0610" class="elsevierStylePara elsevierViewall">This situation especially applies to patients with prolactin-secreting adenomas. In these cases, treatment with a dopamine agonist not only controls prolactin levels, but also decreases tumor size.<a class="elsevierStyleCrossRef" href="#bib0175"><span class="elsevierStyleSup">35</span></a></p><p id="par0615" class="elsevierStylePara elsevierViewall">An overview has been made of the different criteria upon which decisions regarding initial treatment are taken. The form of presentation of the PA, its clinical course, a good response to glucocorticoid treatment, and the availability of an experienced neurosurgeon should all be considered.<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">36</span></a> Some studies have proposed the analysis of radiographic characteristics.<a class="elsevierStyleCrossRefs" href="#bib0190"><span class="elsevierStyleSup">38,41</span></a> Uncontrolled studies have reported that the presence of a single hypodense area inside the tumor, as well as the early involution of the lesion, is often associated with the spontaneous resolution of the condition, which would support the maintenance of conservative management in these cases.<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">38</span></a></p><p id="par0620" class="elsevierStylePara elsevierViewall">A recently published study proposed the use of a scoring scale that allows for establishing PA severity, based on the Glasgow scale, visual acuity, the presence of visual field defects, and the degree of oculomotor palsy.<a class="elsevierStyleCrossRef" href="#bib0210"><span class="elsevierStyleSup">42</span></a> This scale may represent a patient assessment tool based on objective data.</p></span><span id="sec0195" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0250">Recommendations for conservative management</span><p id="par0625" class="elsevierStylePara elsevierViewall">Patients with no or mild and stable neuro-ophthalmological symptoms and/or signs may be managed conservatively under close supervision (III, B).</p><p id="par0630" class="elsevierStylePara elsevierViewall">Neurological symptoms should initially be monitored every hour, but the interval may be lengthened to every four to six hours if the course of the disease is favorable and the patient is stable (√).</p><p id="par0635" class="elsevierStylePara elsevierViewall">Visual acuity and visual field defects should be examined daily until a clear trend to improvement is seen (√).</p><p id="par0640" class="elsevierStylePara elsevierViewall">Kidney function and electrolyte levels should be monitored every 24<span class="elsevierStyleHsp" style=""></span>h or more frequently if needed (√).</p></span></span><span id="sec0200" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0255">Recommendations for surgery in patients on initial conservative management</span><p id="par0645" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0120"><li class="elsevierStyleListItem" id="lsti0320"><span class="elsevierStyleLabel">•</span><p id="par0650" class="elsevierStylePara elsevierViewall">In patients with impaired visual acuity or consciousness or a worsening of visual field defects, urgent MRI should be performed to plan for surgical decompression, including ventricular diversion in the event of hydrocephalus (IV, C).</p></li></ul></p></span><span id="sec0205" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0260">Recommendations concerning the treatment decision</span><p id="par0655" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0125"><li class="elsevierStyleListItem" id="lsti0325"><span class="elsevierStyleLabel">•</span><p id="par0660" class="elsevierStylePara elsevierViewall">The decision to perform surgery or conservative management in patients with PA should be taken by a multidisciplinary team including a neurosurgeon, an endocrinologist, and an ophthalmologist (√).</p></li><li class="elsevierStyleListItem" id="lsti0330"><span class="elsevierStyleLabel">•</span><p id="par0665" class="elsevierStylePara elsevierViewall">Treatment alternatives and the therapeutic modality decided upon should clearly be explained to patients, who should provide their informed consent if at all possible (√).</p></li><li class="elsevierStyleListItem" id="lsti0335"><span class="elsevierStyleLabel">•</span><p id="par0670" class="elsevierStylePara elsevierViewall">Patients or their relatives should be given an explanation sheet containing simple and clear information about pituitary tumors and PA (√).</p></li></ul></p></span><span id="sec0210" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0265">Early postoperative follow-up</span><p id="par0675" class="elsevierStylePara elsevierViewall">The postoperative care of patients who undergo surgery for PA is similar to that provided after pituitary tumor surgery.</p><p id="par0680" class="elsevierStylePara elsevierViewall">Postoperative diabetes insipidus occurs in up to 16% of patients who undergo surgery for PA<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a>. Other potential postoperative complications include cortisol deficiency, vision loss, cerebrospinal fluid fistula, and meningitis.</p><p id="par0685" class="elsevierStylePara elsevierViewall">Adrenal and thyroid function should be assessed in the early postoperative period. Cortisol testing on a sample taken at 09:00<span class="elsevierStyleHsp" style=""></span>h is the test of choice for the initial assessment of recently operated patients.<a class="elsevierStyleCrossRef" href="#bib0215"><span class="elsevierStyleSup">43</span></a> Thyroid function (TSH and free thyroxine) should be tested on the third or fourth day after surgery and, if normal, should be assessed again at 6–8 weeks.</p><p id="par0690" class="elsevierStylePara elsevierViewall">Visual acuity, campimetric defects, and oculomotor palsy improve in most patients after surgical decompression.<a class="elsevierStyleCrossRefs" href="#bib0040"><span class="elsevierStyleSup">8,10,11</span></a> Such improvement is seen in the early postoperative period and often continues weeks after surgery.<a class="elsevierStyleCrossRef" href="#bib0220"><span class="elsevierStyleSup">44</span></a></p><span id="sec0215" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0270">Recommendations for clinical monitoring in the early postoperative period</span><span id="sec0220" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0275">Clinical examination</span><p id="par0695" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0130"><li class="elsevierStyleListItem" id="lsti0340"><span class="elsevierStyleLabel">•</span><p id="par0700" class="elsevierStylePara elsevierViewall">During the first 24 or 48<span class="elsevierStyleHsp" style=""></span>h after surgery, patients should be closely monitored to detect potential complications such as diabetes insipidus, vision loss, cerebrospinal fluid fistula, or ACTH/cortisol deficiency. Water balance should be recorded every hour (√).</p></li></ul></p></span></span><span id="sec0225" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0280">Ophthalmological assessment</span><p id="par0705" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0135"><li class="elsevierStyleListItem" id="lsti0345"><span class="elsevierStyleLabel">•</span><p id="par0710" class="elsevierStylePara elsevierViewall">Visual acuity, eye movements, and confrontational campimetry should regularly be examined for the first 48<span class="elsevierStyleHsp" style=""></span>h at the patient's bedside, and when possible, instrumental examination should be performed (a Humphrey analyzer or a Goldmann perimeter) (IV, C).</p></li></ul></p><span id="sec0230" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0285">Laboratory tests. Endocrinological assessment</span><p id="par0715" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0140"><li class="elsevierStyleListItem" id="lsti0350"><span class="elsevierStyleLabel">•</span><p id="par0720" class="elsevierStylePara elsevierViewall">Kidney function and plasma electrolytes and plasma and urine osmolality should be assessed in the first 24 or 48<span class="elsevierStyleHsp" style=""></span>h. These measurements should be performed at least once daily, and more frequently if required by the clinical status (IV, C).</p></li><li class="elsevierStyleListItem" id="lsti0355"><span class="elsevierStyleLabel">•</span><p id="par0725" class="elsevierStylePara elsevierViewall">Cortisol levels should be measured at 09:00 AM on the second or third day after surgery in patients with no prior evidence of ACTH/cortisol deficiency. This requires the discontinuation of hydrocortisone on the evening before sampling (IV, C).</p></li><li class="elsevierStyleListItem" id="lsti0360"><span class="elsevierStyleLabel">•</span><p id="par0730" class="elsevierStylePara elsevierViewall">In patients with ACTH/cortisol deficiency before surgery, treatment with hydrocortisone should be continued until the maintenance dose is achieved. These patients should be re-evaluated at 4 or 8 weeks to determine whether they will require long-term treatment (IV, C).</p></li><li class="elsevierStyleListItem" id="lsti0365"><span class="elsevierStyleLabel">•</span><p id="par0735" class="elsevierStylePara elsevierViewall">Free thyroxine and TSH levels should be measured on the third or fourth day after surgery. If normal levels are found, they should be measured again at 4 or 8 weeks (IV, C).</p></li></ul></p></span><span id="sec0235" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0290">Radiographic assessment</span><p id="par0740" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0145"><li class="elsevierStyleListItem" id="lsti0370"><span class="elsevierStyleLabel">•</span><p id="par0745" class="elsevierStylePara elsevierViewall">If visual impairment is found, urgent MRI should be performed and the patient should be urgently re-evaluated by the neurosurgical team (√).</p></li></ul></p></span></span></span><span id="sec0240" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0295">Long-term follow-up</span><p id="par0750" class="elsevierStylePara elsevierViewall">Different studies have shown that partial or total functional recovery of the anterior pituitary gland occurs in 50% of patients who have suffered PA.<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">17</span></a></p><p id="par0755" class="elsevierStylePara elsevierViewall">After PA, patients evolve in the following days or months to a state of partial or complete hypopituitarism which may be transient or permanent. Approximately 80% of patients will require some type of hormone replacement therapy. GH deficiency is most common (80–90%), followed by deficiencies in gonadotropins (60–80%) and ACTH/cortisol (60–80%), TSH (50–60%), and arginine vasopressin (10–25%).<a class="elsevierStyleCrossRefs" href="#bib0040"><span class="elsevierStyleSup">8,18,19,38</span></a></p><p id="par0760" class="elsevierStylePara elsevierViewall">An improvement in visual signs after initial treatment often persists or even continues during follow-up. Recovery is less likely in patients who have experienced unilateral or bilateral visual loss.<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">38</span></a> Diplopia is the symptom that remits first, while visual field reduction improves more slowly.<a class="elsevierStyleCrossRefs" href="#bib0150"><span class="elsevierStyleSup">30,44</span></a> OCT provides information not previously available in pituitary disease, is easy to perform, and has no contraindications. It should therefore be included in routine examination of these patients in the mid-term follow-up, because it may help determine the prognosis of visual field lesions.</p><p id="par0765" class="elsevierStylePara elsevierViewall">The recurrence of apoplexy, as well as tumor growth or recurrence, has been reported in both patients on conservative management and those undergoing surgery.<a class="elsevierStyleCrossRefs" href="#bib0020"><span class="elsevierStyleSup">4,9,18,39</span></a> Long-term follow-up of all patients to detect potential recurrence is therefore needed.<a class="elsevierStyleCrossRef" href="#bib0225"><span class="elsevierStyleSup">45</span></a></p><span id="sec0245" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0300">Recommendations for mid- and long-term follow-up</span><p id="par0770" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0150"><li class="elsevierStyleListItem" id="lsti0375"><span class="elsevierStyleLabel">•</span><p id="par0775" class="elsevierStylePara elsevierViewall">All patients who have experienced PA should be assessed 4 or 8 weeks after the acute episode. Pituitary function tests (baseline measurements and, when indicated, the relevant stimulation/suppression tests), cranial nerve examination, and campimetry and, optionally, OCT should be performed (√).</p></li><li class="elsevierStyleListItem" id="lsti0380"><span class="elsevierStyleLabel">•</span><p id="par0780" class="elsevierStylePara elsevierViewall">All patients who have experienced apoplexy should be assessed annually using biochemical tests and pituitary function tests including cortisol, free thyroxine, TSH, LH, FSH, testosterone in men, estradiol in women of childbearing age, prolactin, IGF-1, and dynamic cortisol and GH tests if clinically indicated (√).</p></li><li class="elsevierStyleListItem" id="lsti0385"><span class="elsevierStyleLabel">•</span><p id="par0785" class="elsevierStylePara elsevierViewall">Patients who have experienced apoplexy and have residual tumor will require radiographic follow-up (MRI) and, when indicated, should complete their treatment with repeat surgery, medical treatment, or radiotherapy (III, B).</p></li><li class="elsevierStyleListItem" id="lsti0390"><span class="elsevierStyleLabel">•</span><p id="par0790" class="elsevierStylePara elsevierViewall">Control MRI is recommended 3 or 6 months after apoplexy. If residual tumor or recurrence is found, monitoring is recommended every year during the first 3 or 5 years, and every 2 or 3 years thereafter (IV, C).</p></li><li class="elsevierStyleListItem" id="lsti0395"><span class="elsevierStyleLabel">•</span><p id="par0795" class="elsevierStylePara elsevierViewall">At least annual monitoring is required in all patients. It is recommended that patients be followed up by a multidisciplinary team experienced in pituitary disease (endocrinologists, neurosurgeons, and radiologists) (√).</p></li></ul></p></span><span id="sec0250" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0305">Areas for development</span><p id="par0800" class="elsevierStylePara elsevierViewall">Prospective and/or controlled and/or randomized studies are needed to answer the following questions:<ul class="elsevierStyleList" id="lis0155"><li class="elsevierStyleListItem" id="lsti0400"><span class="elsevierStyleLabel">•</span><p id="par0805" class="elsevierStylePara elsevierViewall">When is the best time for performing surgical decompression when it is required?</p></li><li class="elsevierStyleListItem" id="lsti0405"><span class="elsevierStyleLabel">•</span><p id="par0810" class="elsevierStylePara elsevierViewall">Which patients will benefit from surgery as compared to conservative management? Can a clinical grading scale allowing for the differentiation of these patients be developed and validated?</p></li><li class="elsevierStyleListItem" id="lsti0410"><span class="elsevierStyleLabel">•</span><p id="par0815" class="elsevierStylePara elsevierViewall">What is the long term neuro-ophthalmological and endocrinological prognosis of surgically treated versus conservatively managed patients?</p></li></ul></p></span></span><span id="sec0255" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0310">Conflicts of interest</span><p id="par0820" class="elsevierStylePara elsevierViewall">The authors state that they have no conflicts of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:20 [ 0 => array:2 [ "identificador" => "xres311184" "titulo" => array:4 [ 0 => "Abstract" 1 => "Objective" 2 => "Methods" 3 => "Conclusions" ] ] 1 => array:2 [ "identificador" => "xpalclavsec294338" "titulo" => "Keywords" ] 2 => array:2 [ "identificador" => "xpalclavsec294337" "titulo" => "Abbreviations" ] 3 => array:2 [ "identificador" => "xres311185" "titulo" => array:4 [ 0 => "Resumen" 1 => "Objetivo" 2 => "Métodos" 3 => "Conclusiones" ] ] 4 => array:2 [ "identificador" => "xpalclavsec294336" "titulo" => "Palabras clave" ] 5 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 6 => array:3 [ "identificador" => "sec0010" "titulo" => "Summary of recommendations" "secciones" => array:7 [ 0 => array:3 [ "identificador" => "sec0015" "titulo" => "Recommendations for the initial clinical assessment" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "sec0020" "titulo" => "Clinical examination" ] 1 => array:2 [ "identificador" => "sec0025" "titulo" => "Ophthalmological assessment" ] 2 => array:2 [ "identificador" => "sec0030" "titulo" => "Laboratory tests. Endocrinological assessment" ] 3 => array:2 [ "identificador" => "sec0035" "titulo" => "Radiographic assessment" ] ] ] 1 => array:2 [ "identificador" => "sec0040" "titulo" => "Recommendations for initial medical treatment" ] 2 => array:2 [ "identificador" => "sec0045" "titulo" => "Recommendations for surgery" ] 3 => array:2 [ "identificador" => "sec0050" "titulo" => "Recommendations for conservative management" ] 4 => array:2 [ "identificador" => "sec0055" "titulo" => "Recommendations for surgery in patients on initial conservative management" ] 5 => array:3 [ "identificador" => "sec0060" "titulo" => "Recommendations for clinical monitoring in the early postoperative period" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "sec0065" "titulo" => "Clinical examination" ] 1 => array:2 [ "identificador" => "sec0070" "titulo" => "Ophthalmological assessment" ] 2 => array:2 [ "identificador" => "sec0075" "titulo" => "Laboratory tests. Endocrinological assessment" ] 3 => array:2 [ "identificador" => "sec0080" "titulo" => "Radiographic assessment" ] ] ] 6 => array:2 [ "identificador" => "sec0085" "titulo" => "Recommendations for mid or long-term follow-up" ] ] ] 7 => array:3 [ "identificador" => "sec0090" "titulo" => "Preparation method" "secciones" => array:1 [ 0 => array:3 [ "identificador" => "sec0095" "titulo" => "Levels of evidence and grades of recommendation used (based on the system proposed by the Agency for Health Care Policy and Research)" "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0100" "titulo" => "Levels of evidence" ] 1 => array:2 [ "identificador" => "sec0105" "titulo" => "Grades of recommendation" ] ] ] ] ] 8 => array:2 [ "identificador" => "sec0110" "titulo" => "Definition" ] 9 => array:2 [ "identificador" => "sec0115" "titulo" => "Epidemiology" ] 10 => array:3 [ "identificador" => "sec0120" "titulo" => "Pathophysiology" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0125" "titulo" => "Precipitating factors" ] ] ] 11 => array:2 [ "identificador" => "sec0130" "titulo" => "Clinical signs" ] 12 => array:3 [ "identificador" => "sec0135" "titulo" => "Diagnosis" "secciones" => array:1 [ 0 => array:3 [ "identificador" => "sec0140" "titulo" => "Recommendations for clinical assessment at the onset of pituitary apoplexy" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "sec0145" "titulo" => "Clinical examination" ] 1 => array:2 [ "identificador" => "sec0150" "titulo" => "Ophthalmological assessment" ] 2 => array:2 [ "identificador" => "sec0155" "titulo" => "Laboratory tests. Endocrinological assessment" ] 3 => array:2 [ "identificador" => "sec0160" "titulo" => "Radiographic assessment" ] ] ] ] ] 13 => array:3 [ "identificador" => "sec0165" "titulo" => "Treatment" "secciones" => array:6 [ 0 => array:2 [ "identificador" => "sec0170" "titulo" => "Medical treatment" ] 1 => array:2 [ "identificador" => "sec0175" "titulo" => "Recommendations for initial medical treatment" ] 2 => array:2 [ "identificador" => "sec0180" "titulo" => "Surgery" ] 3 => array:2 [ "identificador" => "sec0185" "titulo" => "Recommendations for surgery" ] 4 => array:2 [ "identificador" => "sec0190" "titulo" => "Surgical versus conservative management" ] 5 => array:2 [ "identificador" => "sec0195" "titulo" => "Recommendations for conservative management" ] ] ] 14 => array:2 [ "identificador" => "sec0200" "titulo" => "Recommendations for surgery in patients on initial conservative management" ] 15 => array:2 [ "identificador" => "sec0205" "titulo" => "Recommendations concerning the treatment decision" ] 16 => array:3 [ "identificador" => "sec0210" "titulo" => "Early postoperative follow-up" "secciones" => array:2 [ 0 => array:3 [ "identificador" => "sec0215" "titulo" => "Recommendations for clinical monitoring in the early postoperative period" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0220" "titulo" => "Clinical examination" ] ] ] 1 => array:3 [ "identificador" => "sec0225" "titulo" => "Ophthalmological assessment" "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0230" "titulo" => "Laboratory tests. Endocrinological assessment" ] 1 => array:2 [ "identificador" => "sec0235" "titulo" => "Radiographic assessment" ] ] ] ] ] 17 => array:3 [ "identificador" => "sec0240" "titulo" => "Long-term follow-up" "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0245" "titulo" => "Recommendations for mid- and long-term follow-up" ] 1 => array:2 [ "identificador" => "sec0250" "titulo" => "Areas for development" ] ] ] 18 => array:2 [ "identificador" => "sec0255" "titulo" => "Conflicts of interest" ] 19 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2012-10-26" "fechaAceptado" => "2013-04-10" "PalabrasClave" => array:2 [ "en" => array:2 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec294338" "palabras" => array:3 [ 0 => "Pituitary tumor" 1 => "Pituitary apoplexy" 2 => "Apoplectic stroke" ] ] 1 => array:4 [ "clase" => "abr" "titulo" => "Abbreviations" "identificador" => "xpalclavsec294337" "palabras" => array:10 [ 0 => "AHCPR (AHRQ)" 1 => "PA" 2 => "GnRH" 3 => "CRH" 4 => "GH" 5 => "ACTH" 6 => "MRI" 7 => "CT" 8 => "OCT" 9 => "RNFL" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec294336" "palabras" => array:3 [ 0 => "Tumor hipofisario" 1 => "Apoplejía hipofisaria" 2 => "Ictus apopléctico" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Classic pituitary apoplexy (PA) is an acute, life-threatening clinical syndrome caused by acute hemorrhage and/or infarction of the pituitary gland. PA is considered a neuroendocrinological emergency. However, there is no consensus about the best options for PA diagnosis and management.</p> <span class="elsevierStyleSectionTitle" id="sect0010">Objective</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">To develop a clinical practice guideline with a number of recommendations for diagnosis and treatment of patients with PA based on the medical evidence available, in order to help clinicians involved in their care.</p> <span class="elsevierStyleSectionTitle" id="sect0015">Methods</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">The clinical guideline for diagnosis and treatment of pituitary apoplexy issued in 2006 by the Neuroendocrinology Working Group of the Spanish Society of Endocrinology and Nutrition (SEEN) and the British Clinical Practice Guideline published in 2011 were taken as the basis. The text has been adapted to the format used in most international medical journals. For this, after updated medical literature, the quality of evidence and the strength of the recommendations were evaluated using the system proposed by the Agency for Health Care Policy and Research (AHCPR).</p> <span class="elsevierStyleSectionTitle" id="sect0020">Conclusions</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Diagnosis of pituitary apoplexy should be considered in all patients with acute severe headache with or without neuro-ophthalmic signs. Patients with PA must undergo a complete history and physical examination. All patients with suspected pituitary apoplexy should have urgent blood samples drawn to test electrolytes, renal function, liver function, coagulation screen, complete blood count, and basal levels of pituitary and peripheral hormones, and to rule out adrenocorticotropic hormone (ACTH) deficiency. Formal visual field assessment should be performed when the patient is clinically stable. Magnetic resonance imaging (MRI) is the imaging test of choice to confirm diagnosis. Indications for empirical urgent corticosteroid therapy in patients with PA include hemodynamic instability, impaired consciousness, reduced visual acuity, and severe visual field defects. In patients with these severe neuro-ophthalmic signs, surgery should be considered. Surgery should preferably be performed within seven days of the onset of symptoms. Patients with mild and stable signs may be managed conservatively with careful monitoring. Treatment and long-term follow-up of patients with PA should be conducted by a multidisciplinary team consisting, amongst others, of an experienced pituitary neurosurgeon, an ophthalmologist, and an endocrinologist.</p>" ] "es" => array:2 [ "titulo" => "Resumen" "resumen" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">La apoplejía hipofisaria (AH) clásica es un síndrome clínico agudo, potencialmente fatal, provocado por la hemorragia y/o infarto de la glándula hipofisaria. Constituye uno de los cuadros clínicos de urgencia neuroendocrinológica. Sin embargo, no existe un consenso claro sobre cuáles pueden ser las mejores opciones para su diagnóstico y tratamiento.</p> <span class="elsevierStyleSectionTitle" id="sect0030">Objetivo</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Elaborar una guía de práctica clínica con una serie de recomendaciones para el diagnóstico y tratamiento de los pacientes con AH basadas en la evidencia médica disponible, que sirva de ayuda a los profesionales implicados en su cuidado.</p> <span class="elsevierStyleSectionTitle" id="sect0035">Métodos</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Se ha tomado como base la guía clínica de diagnóstico y tratamiento de la apoplejía hipofisaria, publicada en el año 2006 por el Grupo de Trabajo de Neuroendocrinología de la Sociedad Española de Endocrinología y Nutrición (SEEN), así como la Guía Británica de Práctica Clínica publicada en 2011. Se ha trabajado en la adaptación al formato utilizado en la mayoría de las revistas médicas internacionales. Para ello, tras la revisión bibliográfica actualizada, se ha evaluado la calidad de la evidencia y el peso de las recomendaciones de acuerdo con el sistema propuesto por la <span class="elsevierStyleItalic">Agency for Health Care Policy and Research</span> (AHCPR).</p> <span class="elsevierStyleSectionTitle" id="sect0040">Conclusiones</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">El diagnóstico de apoplejía hipofisaria debería valorarse en aquellos pacientes con cefalea aguda grave, con o sin síntomas neurooftalmológicos. Se realizará una evaluación clínica completa. La evaluación analítica urgente incluirá medición de electrólitos, función renal y hepática, hemograma y estudio de coagulación y concentraciones basales de hormonas hipofisarias y periféricas. Será crucial descartar el déficit de hormona adrenocorticotropa (ACTH). Si el estado del paciente lo permite, debe realizarse una campimetría y una resonancia magnética (RM) urgente para confirmar el diagnóstico. En pacientes con inestabilidad hemodinámica, disminución de nivel de conciencia, disminución de la agudeza visual y defectos extensos en el campo visual se recomienda realizar descompresión quirúrgica en la primera semana tras el inicio de los síntomas. Los pacientes con sintomatología más leve pueden ser tratados de forma conservadora, bajo supervisión estrecha. El tratamiento de la AH debería realizarse en un centro donde exista disponibilidad y experiencia en el tratamiento neuroquirúrgico por vía transesfenoidal y posibilidad de seguimiento oftalmológico y endocrinológico.</p>" ] ] "NotaPie" => array:2 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Vicente A, Lecumberri B, Gálvez MÁ, en nombre del Grupo de Trabajo de Neuroendocrinología. Guía de práctica clínica para el diagnóstico y tratamiento de la apoplejía hipofisaria. Endocrinol Nutr. 2013;60:582–582.</p>" ] 1 => array:2 [ "etiqueta" => "◊" "nota" => "<p class="elsevierStyleNotepara" id="npar0010">The names of the components of the Neuroendocrinology working group are related in Annex at the end of the article.</p>" ] ] "multimedia" => array:3 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2716 "Ancho" => 2156 "Tamanyo" => 382494 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Algorithm for the management of pituitary apoplexy. MRI: magnetic resonance imaging; CT: computed tomography.</p>" ] ] 1 => array:7 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">High blood pressure (26%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Major surgery (coronary bypass) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Dynamic pituitary function tests with GnRH, TRH, and CRH \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Anticoagulant treatment \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Coagulopathies \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Estrogens \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Start or discontinuation of treatment with dopamine agonists \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Radiotherapy \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Pregnancy \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Large macroadenomas (corticotropinomas) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Somatostatin analogs and paramagnetic contrast media (exceptional) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Head trauma \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab457214.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Precipitating factors in pituitary apoplexy.</p>" ] ] 2 => array:7 [ "identificador" => "tbl0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "leyenda" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleItalic">Source</span>: Randeva et al.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a> and Sibal et al.<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">12</span></a></p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Symptoms and signs \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Percentage \t\t\t\t\t\t\n \t\t\t\t</td></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Headache</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">95 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Nausea</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">80 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Visual field reduction</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">71 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Cranial nerve involvement</span></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleSmallCaps"><span class="elsevierStyleHsp" style=""></span>iii</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">67 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleSmallCaps"><span class="elsevierStyleHsp" style=""></span>iv</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">4 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleSmallCaps"><span class="elsevierStyleHsp" style=""></span>vi</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">29 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Decreased visual acuity</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">66 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Vomiting</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">57 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Photophobia</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">49 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Fever</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">20 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Impaired consciousness</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">11 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab457213.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Symptoms and signs occurring in pituitary apoplexy.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:45 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Guía clínica del diagnóstico y tratamiento de la apoplejía hipofisaria" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Català" 1 => "A. Picó" 2 => "F. Tortosa" 3 => "C. Varela" 4 => "A. Gilsanz" 5 => "T. Lucas" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Endocrinol Nutr" "fecha" => "2006" "volumen" => "53" "paginaInicial" => "19" "paginaFinal" => "24" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "UK guidelines for the management of pituitary apoplexy. Pituitary Apoplexy Guidelines Development Group: May 2010" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Rajasekaran" 1 => "M. Vanderpump" 2 => "S. Baldeweg" 3 => "W. Drake" 4 => "N. Reddy" 5 => "M. Lanyon" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Clin Endocrinol (Oxf)" "fecha" => "2011" "volumen" => "74" "paginaInicial" => "9" "paginaFinal" => "20" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches. The GRADE Working Group" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "D. Atkins" 1 => "M. Eccles" 2 => "S. Fottorp" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/1472-6963-4-38" "Revista" => array:5 [ "tituloSerie" => "BMC Health Serv Res" "fecha" => "2004" "volumen" => "4" "paginaInicial" => "38" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15615589" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Acute degenerative changes in adenomas of the pituitary body: with special reference to pituitary apoplexy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "M. Brougham" 1 => "A.P. Heusner" 2 => "R.D. Adams" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3171/jns.1950.7.5.0421" "Revista" => array:6 [ "tituloSerie" => "J Neurosurg" "fecha" => "1950" "volumen" => "7" "paginaInicial" => "421" "paginaFinal" => "439" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14774761" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pathological report of a case of acromegaly, with special reference to the lesions in the hypophysis cerebri and in the thyroid gland; and a case of haemorrhage in to the pituitary" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "P. Bailey" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Philadelphia Med J" "fecha" => "1898" "volumen" => "1" "paginaInicial" => "789" "paginaFinal" => "792" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pituitary apoplexy: a review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "E.R. Cardoso" 1 => "E.W. Peterson" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Neurosurgery" "fecha" => "1984" "volumen" => "14" "paginaInicial" => "363" "paginaFinal" => "373" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/6369168" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pituitary apoplexy: do histological features influence the clinical presentation and outcome?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "P.L. Semple" 1 => "J.C. de Villiers" 2 => "R.M. Bowen" 3 => "M.B.S. Lopes" 4 => "E.R. Laws Jr." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Neurosurg" "fecha" => "2006" "volumen" => "104" "paginaInicial" => "931" "paginaFinal" => "937" ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Classical pituitary apoplexy: clinical features, management and outcome" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "H.S. Randeva" 1 => "J. Schoebel" 2 => "J. Byrne" 3 => "M. Esiri" 4 => "C.B.T. Adams" 5 => "J.A.H. Wass" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Clin Endocrinol (Oxf)" "fecha" => "1999" "volumen" => "51" "paginaInicial" => "181" "paginaFinal" => "188" ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pituitary apoplexy. Association of degenerative change in pituitary adenoma with radiotherapy and detection by cerebral computed tomography" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "L.A. Weisberg" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Am J Med" "fecha" => "1977" "volumen" => "63" "paginaInicial" => "109" "paginaFinal" => "115" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/879188" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical versus subclinical pituitary apoplexy: presentation, surgical management, and outcome in 21 patients" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "S.T. Onesti" 1 => "T. Wisniewski" 2 => "K.D. Post" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Neurosurgery" "fecha" => "1990" "volumen" => "26" "paginaInicial" => "980" "paginaFinal" => "986" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/2362675" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0055" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A retrospective analysis of pituitary apoplexy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D.C. Bills" 1 => "F.B. Meyer" 2 => "E.R. Laws Jr." 3 => "D.H. Davis" 4 => "M.J. Ebersold" 5 => "B.W. Scheithuer" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Neurosurgery" "fecha" => "1993" "volumen" => "33" "paginaInicial" => "602" "paginaFinal" => "608" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8232799" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0060" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pituitary apoplexy: a review of clinical presentation, management and outcome in 45 cases" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "L. Sibal" 1 => "S.G. Ball" 2 => "V. Connolly" 3 => "R.A. James" 4 => "P. Kane" 5 => "W.F. Kelly" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s11102-005-1050-3" "Revista" => array:6 [ "tituloSerie" => "Pituitary" "fecha" => "2004" "volumen" => "7" "paginaInicial" => "157" "paginaFinal" => "163" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16010459" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0065" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pituitary apoplexy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "P.L. Semple" 1 => "M.K. Webb" 2 => "J.C. de Villiers" 3 => "E.R. Laws Jr." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Neurosurgery" "fecha" => "2005" "volumen" => "56" "paginaInicial" => "65" "paginaFinal" => "73" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15617587" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0070" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical features and surgical outcome of clinical and subclinical pituitary apoplexy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "Z.H. Liu" 1 => "C.N. Chang" 2 => "P.C. Pai" 3 => "K.C. Wei" 4 => "S.M. Jung" 5 => "N.Y. Chen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jocn.2009.11.012" "Revista" => array:6 [ "tituloSerie" => "J Clin Neurosci" "fecha" => "2010" "volumen" => "17" "paginaInicial" => "694" "paginaFinal" => "699" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20400318" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0075" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pituitary apoplexy: endocrine, surgical and oncological emergency. Incidence, clinical course and treatment with reference to 799 cases of pituitary adenomas" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "W. Bonicki" 1 => "A. Kasperlik-Zaluska" 2 => "W. Koszewski" 3 => "W. Zglyczynsky" 4 => "J. Wislawski" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Acta Neurochir (Wien)" "fecha" => "1993" "volumen" => "120" "paginaInicial" => "118" "paginaFinal" => "122" ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0080" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hemorrhage, necrosis, and apoplexy in pituitary adenomas" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "G. Mohr" 1 => "J. Hardy" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Surg Neurol" "fecha" => "1982" "volumen" => "18" "paginaInicial" => "181" "paginaFinal" => "189" ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0085" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Extreme elevation of intrasellar pressure in patients with pituitary tumor apoplexy: relation to pituitary function" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "D.H. Zayour" 1 => "W.R. Selman" 2 => "B.M. Arafah" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jc.2004-0884" "Revista" => array:6 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "2004" "volumen" => "89" "paginaInicial" => "5649" "paginaFinal" => "5654" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15531524" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0090" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Acute management of pituitary apoplexy–surgery or conservative management?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "J. Ayuk" 1 => "E.J. McGregor" 2 => "R.D. Mitchell" 3 => "N.J.L. Gittoes" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Clin Endocrinol (Oxf)" "fecha" => "2004" "volumen" => "61" "paginaInicial" => "747" "paginaFinal" => "752" ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0095" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pituitary apoplexy: analysis of endocrine function in 17 cases" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.M. Fernández Real" 1 => "C.M. Villabona" 2 => "E. Montaña" 3 => "J.J. Acebes" 4 => "W. Ricart" 5 => "M. Sahún" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Med Clin (Barc)" "fecha" => "1991" "volumen" => "96" "paginaInicial" => "521" "paginaFinal" => "524" ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0100" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Anterior pituitary failure" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "C.H.F. Abboud" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:5 [ "titulo" => "The pituitary" "paginaInicial" => "349" "paginaFinal" => "401" "edicion" => "2nd ed." "serieFecha" => "2002" ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0105" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Acute visual loss and pituitary apoplexy after surgery" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J. Abbott" 1 => "G.R. Kirkby" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/bmj.329.7459.218" "Revista" => array:6 [ "tituloSerie" => "BMJ" "fecha" => "2004" "volumen" => "329" "paginaInicial" => "218" "paginaFinal" => "219" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15271834" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0110" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Ptosis postcardiac surgery: a case of pituitary apoplexy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "A. Alzetani" 1 => "C. Fisher" 2 => "R. Costa" 3 => "S.K. Ohri" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Ann Thorac Surg" "fecha" => "2002" "volumen" => "73" "paginaInicial" => "300" "paginaFinal" => "301" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11834035" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0115" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pituitary adenomas complicating cardiac surgery: summary and review of 11 cases" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "M.B. Pliam" 1 => "M. Cohen" 2 => "L. Cheng" 3 => "M. Spaenle" 4 => "M.H. Bronstein" 5 => "T.W. Atkin" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Cardiac Surg" "fecha" => "1995" "volumen" => "10" "paginaInicial" => "125" "paginaFinal" => "132" ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0120" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hazards of dynamic testing of pituitary function" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "A. Levy" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Clin Endocrinol (Oxf)" "fecha" => "2003" "volumen" => "58" "paginaInicial" => "543" "paginaFinal" => "544" ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0125" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pituitary apoplexy presenting during pregnancy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "L.J. de Heide" 1 => "K.M. van Tol" 2 => "B. Doorenbos" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Neth J Med" "fecha" => "2004" "volumen" => "62" "paginaInicial" => "393" "paginaFinal" => "396" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15683096" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0130" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Postoperative ‘pituitary apoplexy’ in giant pituitary adenomas: a series of cases" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "F.U. Ahmad" 1 => "P. Pandy" 2 => "A.K. Mahapatra" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Neurol India" "fecha" => "2005" "volumen" => "53" "paginaInicial" => "326" "paginaFinal" => "328" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16230802" "web" => "Medline" ] ] ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0135" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Adenomas corticotropos silentes: presentación de 2 casos que han presentado apoplejía hipofisaria" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Lagares" 1 => "P. González" 2 => "S. Miranda" 3 => "A. Cabrera" 4 => "R.D. Lobato" 5 => "A. Ramos" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Neurocirugía" "fecha" => "2004" "volumen" => "15" "paginaInicial" => "159" "paginaFinal" => "164" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15159794" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0264410X13005872" "estado" => "S300" "issn" => "0264410X" ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0140" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Classiccal pituitary tumour apoplexy: clinical features, management and outcomes in a series of 24 patients" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "A.S. Dubuisson" 1 => "A. Beckers" 2 => "A. Etevenaert" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Clin Neurol Neurosurg" "fecha" => "2007" "volumen" => "109" "paginaInicial" => "100" "paginaFinal" => "107" ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0145" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immediate recovery of pituitary function after transsphenoidal resection of pituitary macroadenomas" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "B.M. Arafah" 1 => "S.H. Kailani" 2 => "K.E. Nekl" 3 => "R.S. Gold" 4 => "W.R. Selman" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jcem.79.2.8045946" "Revista" => array:6 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "1994" "volumen" => "79" "paginaInicial" => "348" "paginaFinal" => "354" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8045946" "web" => "Medline" ] ] ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0150" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The time course of visual field recovery and changes of retinal ganglion cells alter optic chiasmal descompression" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Ch. Moon" 1 => "S.C. Hwang" 2 => "Y.H. Ohn" 3 => "T.K. Park" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1167/iovs.11-7450" "Revista" => array:6 [ "tituloSerie" => "Invest Ophthalmol Vis Sci" "fecha" => "2011" "volumen" => "52" "paginaInicial" => "7966" "paginaFinal" => "7973" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21896856" "web" => "Medline" ] ] ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0155" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The role of retinal nerve fiber layer in predicting recovery of vision following surgery for pituitary adenomas" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "H.V. Danesh-Meyer" 1 => "P.J. Savino" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Am J Ophthalmol" "fecha" => "2009" "volumen" => "147" "paginaInicial" => "103" "paginaFinal" => "104" ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib0160" "etiqueta" => "32" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Neuro-ophthalmological manifestations of pituitary adenomas. The usefulness of optical coherence tomography" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "S. Ortiz-Pérez" 1 => "B.F. Sánchez-Dalmau" 2 => "J.J. Molina-Fernández" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Rev Neurol" "fecha" => "2009" "volumen" => "48" "paginaInicial" => "85" "paginaFinal" => "90" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19173206" "web" => "Medline" ] ] ] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib0165" "etiqueta" => "33" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Assessment of hemorrhage in pituitary macroadenoma by T2-weighted gradient-echo MR imaging" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Tosaka" 1 => "M. Sato" 2 => "J. Hirato" 3 => "H. Fujimaki" 4 => "R. Yamaguchi" 5 => "H. Kohga" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3174/ajnr.A0692" "Revista" => array:6 [ "tituloSerie" => "Am J Neuroradiol" "fecha" => "2007" "volumen" => "28" "paginaInicial" => "2023" "paginaFinal" => "2029" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17898201" "web" => "Medline" ] ] ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib0170" "etiqueta" => "34" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pituitary apoplexy. Clinical course, endocrine evaluations and treatment anlysis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "L.A. da Motta" 1 => "P.A. de Mello" 2 => "C.M. de Lacerda" 3 => "A.P. Neto" 4 => "L.D. da Motta" 5 => "M.F. Filho" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Neurosurg Sci" "fecha" => "1999" "volumen" => "43" "paginaInicial" => "25" "paginaFinal" => "36" ] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib0175" "etiqueta" => "35" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pituitary tumor apoplexy: a review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "R.N. Nawar" 1 => "D. Abdelmannan" 2 => "W.R. Selman" 3 => "B.M. Arafah" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0885066607312992" "Revista" => array:6 [ "tituloSerie" => "J Intensive Care Med" "fecha" => "2008" "volumen" => "23" "paginaInicial" => "75" "paginaFinal" => "90" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18372348" "web" => "Medline" ] ] ] ] ] ] ] ] 35 => array:3 [ "identificador" => "bib0180" "etiqueta" => "36" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pituitary apoplexy: an overview of 186 cases published during the last century" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "M. Turgut" 1 => "Y. Özsunar" 2 => "S. Başak" 3 => "E. Güney" 4 => "E. Kır" 5 => "I. Meteoğlu" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00701-009-0595-8" "Revista" => array:6 [ "tituloSerie" => "Acta Neurochir" "fecha" => "2010" "volumen" => "152" "paginaInicial" => "749" "paginaFinal" => "761" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20140630" "web" => "Medline" ] ] ] ] ] ] ] ] 36 => array:3 [ "identificador" => "bib0185" "etiqueta" => "37" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Blindness following pituitary apoplexy: timing of surgery and neuro-ophthalmic outcome" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "N. Muthukumar" 1 => "D. Rossette" 2 => "M. Soundaram" 3 => "S. Senthilbabu" 4 => "T. Badrinayanaran" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jocn.2007.08.010" "Revista" => array:6 [ "tituloSerie" => "J Clin Neurosci" "fecha" => "2008" "volumen" => "15" "paginaInicial" => "873" "paginaFinal" => "879" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18502643" "web" => "Medline" ] ] ] ] ] ] ] ] 37 => array:3 [ "identificador" => "bib0190" "etiqueta" => "38" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Conservative management of pituitary apoplexy: a prospective study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "P. Maccagnan" 1 => "C.L. Macedo" 2 => "M.J. Kayath" 3 => "R.G. Nogueira" 4 => "J. Abucham" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jcem.80.7.7608278" "Revista" => array:6 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "1995" "volumen" => "80" "paginaInicial" => "2190" "paginaFinal" => "2197" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7608278" "web" => "Medline" ] ] ] ] ] ] ] ] 38 => array:3 [ "identificador" => "bib0195" "etiqueta" => "39" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pituitary apoplexy: retrospective review of 30 patients – is surgical intervention always necessary?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "A. Gruber" 1 => "J. Clayton" 2 => "S. Kumar" 3 => "I. Robertson" 4 => "T.A. Howlett" 5 => "P. Mansell" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Br J Neurosurg" "fecha" => "2006" "volumen" => "20" "paginaInicial" => "379" "paginaFinal" => "385" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17439089" "web" => "Medline" ] ] ] ] ] ] ] ] 39 => array:3 [ "identificador" => "bib0200" "etiqueta" => "40" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A conservative management is preferable in milder forms of pituitary tumor apoplexy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Leyer" 1 => "F. Castinetti" 2 => "I. Morange" 3 => "M. Gueydan" 4 => "C. Oliver" 5 => "B. Conte-Devolx" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Endocrinol Invest" "fecha" => "2011" "volumen" => "34" "paginaInicial" => "502" "paginaFinal" => "509" ] ] ] ] ] ] 40 => array:3 [ "identificador" => "bib0205" "etiqueta" => "41" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The various MRI patterns of pituitary apoplexy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Piotin" 1 => "D. Tampieri" 2 => "D.A. Rufenacht" 3 => "G. Mohr" 4 => "M. Garant" 5 => "R. del Carpio" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s003300050767" "Revista" => array:6 [ "tituloSerie" => "Eur Radiol" "fecha" => "1999" "volumen" => "9" "paginaInicial" => "918" "paginaFinal" => "923" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10369991" "web" => "Medline" ] ] ] ] ] ] ] ] 41 => array:3 [ "identificador" => "bib0210" "etiqueta" => "42" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "An objective scoring tool in the management of patients with pituitary apoplexy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "N.L. Reddy" 1 => "S. Rajasekaran" 2 => "T.S. Han" 3 => "A. Theodoraki" 4 => "W. Drake" 5 => "M. Vanderpump" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Clin Endocrinol (Oxf)" "fecha" => "2011" "volumen" => "75" "paginaInicial" => "723" ] ] ] ] ] ] 42 => array:3 [ "identificador" => "bib0215" "etiqueta" => "43" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Should posthipophysectomy patients be dicharged on steroids? The use of 0900h-cortisol measurements as a screening test for pituitary–adrenal dysfunction. P91" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "J.N. Walker" 1 => "E. Nickerson" 2 => "S.G. Gardner" 3 => "B. Shine" 4 => "H.E. Turner" 5 => "J.A.H. Wass" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:3 [ "titulo" => "23rd Joint Meeting of the British Endocrine Societies" "conferencia" => "Brighton" "serieFecha" => "2004" ] ] ] ] ] ] 43 => array:3 [ "identificador" => "bib0220" "etiqueta" => "44" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Stages of improvement in visual fields after pituitary tumor resection" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "J.B. Kerrison" 1 => "M.J. Lynn" 2 => "C.A. Baer" 3 => "S.A. Newman" 4 => "V. Biousse" 5 => "N.J. Newman" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Am J Ophtalmol" "fecha" => "2000" "volumen" => "130" "paginaInicial" => "813" "paginaFinal" => "820" ] ] ] ] ] ] 44 => array:3 [ "identificador" => "bib0225" "etiqueta" => "45" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pituitary apoplexy in non-functioning pituitary adenomas: long term follow up is important because of significant numbers of tumour recurrences" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Pal" 1 => "C. Capatina" 2 => "A.P. Tenreiro" 3 => "P.D. Guardiola" 4 => "J.V. Byrne" 5 => "S. Cudlip" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Clin Endocrinol (Oxf)" "fecha" => "2011" "volumen" => "75" "paginaInicial" => "501" "paginaFinal" => "504" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/21735093/0000006000000010/v2_201402070022/S2173509313002262/v2_201402070022/en/main.assets" "Apartado" => array:4 [ "identificador" => "21321" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Consensus statement" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/21735093/0000006000000010/v2_201402070022/S2173509313002262/v2_201402070022/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173509313002262?idApp=UINPBA00004N" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 24 | 0 | 24 |
2024 October | 222 | 22 | 244 |
2024 September | 320 | 68 | 388 |
2024 August | 238 | 31 | 269 |
2024 July | 327 | 41 | 368 |
2024 June | 289 | 31 | 320 |
2024 May | 354 | 29 | 383 |
2024 April | 287 | 38 | 325 |
2024 March | 325 | 60 | 385 |
2024 February | 352 | 59 | 411 |
2024 January | 484 | 97 | 581 |
2023 December | 418 | 82 | 500 |
2023 November | 498 | 71 | 569 |
2023 October | 602 | 84 | 686 |
2023 September | 402 | 72 | 474 |
2023 August | 294 | 37 | 331 |
2023 July | 270 | 59 | 329 |
2023 June | 270 | 67 | 337 |
2023 May | 332 | 35 | 367 |
2023 April | 299 | 48 | 347 |
2023 March | 249 | 92 | 341 |
2023 February | 164 | 39 | 203 |
2023 January | 206 | 50 | 256 |
2022 December | 185 | 44 | 229 |
2022 November | 203 | 34 | 237 |
2022 October | 160 | 48 | 208 |
2022 September | 190 | 53 | 243 |
2022 August | 177 | 45 | 222 |
2022 July | 150 | 50 | 200 |
2022 June | 163 | 48 | 211 |
2022 May | 226 | 61 | 287 |
2022 April | 193 | 61 | 254 |
2022 March | 249 | 57 | 306 |
2022 February | 219 | 65 | 284 |
2022 January | 237 | 46 | 283 |
2021 December | 183 | 49 | 232 |
2021 November | 216 | 51 | 267 |
2021 October | 215 | 50 | 265 |
2021 September | 197 | 79 | 276 |
2021 August | 168 | 40 | 208 |
2021 July | 151 | 41 | 192 |
2021 June | 152 | 33 | 185 |
2021 May | 185 | 55 | 240 |
2021 April | 404 | 92 | 496 |
2021 March | 226 | 49 | 275 |
2021 February | 185 | 46 | 231 |
2021 January | 226 | 47 | 273 |
2020 December | 146 | 55 | 201 |
2020 November | 150 | 44 | 194 |
2020 October | 68 | 15 | 83 |
2020 September | 85 | 25 | 110 |
2020 August | 82 | 23 | 105 |
2020 July | 58 | 31 | 89 |
2020 June | 43 | 17 | 60 |
2020 May | 71 | 47 | 118 |
2020 April | 55 | 16 | 71 |
2020 March | 87 | 25 | 112 |
2020 February | 33 | 19 | 52 |
2020 January | 46 | 12 | 58 |
2019 December | 13 | 10 | 23 |
2019 November | 18 | 24 | 42 |
2019 October | 23 | 13 | 36 |
2019 September | 32 | 15 | 47 |
2019 August | 21 | 10 | 31 |
2019 July | 19 | 23 | 42 |
2019 June | 54 | 29 | 83 |
2019 May | 149 | 33 | 182 |
2019 April | 77 | 36 | 113 |
2019 March | 19 | 7 | 26 |
2019 February | 27 | 8 | 35 |
2019 January | 26 | 11 | 37 |
2018 December | 29 | 8 | 37 |
2018 November | 29 | 2 | 31 |
2018 October | 30 | 2 | 32 |
2018 September | 36 | 5 | 41 |
2018 August | 29 | 4 | 33 |
2018 July | 26 | 3 | 29 |
2018 June | 22 | 9 | 31 |
2018 May | 17 | 1 | 18 |
2018 April | 20 | 4 | 24 |
2018 March | 15 | 0 | 15 |
2018 February | 19 | 3 | 22 |
2018 January | 12 | 1 | 13 |
2017 December | 19 | 1 | 20 |
2017 November | 15 | 1 | 16 |
2017 October | 16 | 2 | 18 |
2017 September | 22 | 4 | 26 |
2017 August | 33 | 4 | 37 |
2017 July | 22 | 2 | 24 |
2017 June | 34 | 7 | 41 |
2017 May | 26 | 8 | 34 |
2017 April | 26 | 4 | 30 |
2017 March | 24 | 6 | 30 |
2017 February | 33 | 3 | 36 |
2017 January | 10 | 1 | 11 |
2016 December | 23 | 3 | 26 |
2016 November | 23 | 10 | 33 |
2016 October | 27 | 3 | 30 |
2016 September | 33 | 6 | 39 |
2016 August | 32 | 4 | 36 |
2016 July | 25 | 2 | 27 |
2016 June | 32 | 9 | 41 |
2016 May | 33 | 12 | 45 |
2016 April | 25 | 7 | 32 |
2016 March | 27 | 14 | 41 |
2016 February | 21 | 10 | 31 |
2016 January | 32 | 11 | 43 |
2015 December | 24 | 19 | 43 |
2015 November | 28 | 8 | 36 |
2014 February | 1 | 2 | 3 |